CN Patent

CN111671749A — 双香豆素在制备HBx蛋白稳定性抑制剂中的用途

Assigned to Chongqing Medical University · Expires 2020-09-18 · 6y expired

What this patent protects

本发明提供一种双香豆素在制备HBx蛋白稳定性抑制剂中的用途。申请人通过实验发现利用HBx蛋白稳定性抑制剂，特别是双香豆素，可以有效的降低HBx的稳定性，进而抑制HBV病毒的复制，达到治疗乙肝的目的，为乙肝的治疗提供了新的路径，对人类的健康事业具有十分积极的意义。

USPTO Abstract

本发明提供一种双香豆素在制备HBx蛋白稳定性抑制剂中的用途。申请人通过实验发现利用HBx蛋白稳定性抑制剂，特别是双香豆素，可以有效的降低HBx的稳定性，进而抑制HBV病毒的复制，达到治疗乙肝的目的，为乙肝的治疗提供了新的路径，对人类的健康事业具有十分积极的意义。

Drugs covered by this patent

Patent Metadata

Patent number
CN111671749A
Jurisdiction
CN
Classification
—
Expires
2020-09-18
Drug substance claim
No
Drug product claim
No
Assignee
Chongqing Medical University
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.